For the Blood and Marrow Transplantation (BMT)/Immunotherapy fellowship, the Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Medical Oncology are jointly recruiting a full-time advanced fellow at the Research Associate/Acting Instructor (Provisional) level. This is a full-time, 12-month service period, annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.
The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in BMT and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, UW and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.
This is a year-long fellowship program with the goal of becoming an expert in BMT and immunotherapy. Rotations will include outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up, etc.) and immunotherapy services. The fellow will initially function as a primary provider with direct patient care responsibilities and will have increasing levels of clinical team leadership over the course of the year. Approximately 8 months will be devoted to clinical activities with the remaining time available for clinically focused research projects. University of Washington faculty engage in teaching, research, and service.
Anticipated start date: July 1, 2023